What is the duration of intravenous (IV) lidocaine infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Intravenous Lidocaine Infusion

The duration of IV lidocaine infusion should not generally exceed 24 hours for postoperative pain management. 1

Standard Duration Protocol

  • Maximum initial duration is 24 hours for most postoperative patients, as this timeframe is typically sufficient since postoperative pain decreases with time and other analgesics remain available 1

  • Most patients do not benefit from prolonged infusion beyond 24 hours, though exceptions exist for patients with chronic pain 1

Extension Beyond 24 Hours

If extending the infusion beyond 24 hours becomes necessary:

  • Decision must be made by a consultant anaesthetist or intensivist and/or the acute pain team, within the scope of relevant hospital guidelines 1

  • Infusion rate must be reduced to 50% of the original rate when extending beyond 24 hours 1

  • This dose reduction is critical because lidocaine exhibits time-dependent pharmacokinetics after 12 hours of infusion, with the elimination half-life prolonging from approximately 100 minutes to 3.22 hours after 24 hours 1

Pharmacokinetic Rationale

The duration limitation is based on important pharmacokinetic changes:

  • Lidocaine pharmacokinetics are linear and predictable only up to 12 hours of continuous infusion 1

  • After prolonged infusion (>24 hours), the elimination half-life can be prolonged two-fold or more, particularly in patients with liver dysfunction 2

  • The typical elimination half-life is 1.5 to 2.0 hours following bolus injection, but this changes significantly with continuous infusion 2

Critical Safety Considerations

  • Lipid emulsion 20% must be readily available wherever IV lidocaine is used throughout the infusion duration 1, 3

  • Patients should ideally be managed in a monitored bedspace (high dependency unit/level 2 care) outside the operating theatre/recovery room 1

  • Monitoring frequency: Every 15 minutes for the first hour, then hourly as minimum thereafter 1

  • Early signs of toxicity include peri-oral tingling, tinnitus, light-headedness, and restlessness—these neurological symptoms appear before cardiovascular changes 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Assessment and Management of Hand Ischemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.